Side effects tend to be manageablenausea comes up the most, especially early on, but it often fades as things level out
The reference secretagogue in literature on visceral adipose tissue mobilization
Unlike many antioxidants, the body has a dedicated transporter specifically for ergothioneine, highlighting its importance for cellular protection
GIP Agonism Reduces appetite, nausea, and bone resorption Increases insulin & glucagon production, and lipogenesis Glucagon Agonism Reduces appetite, food intake, and gastric emptying Increases insulin production, energy expenditure, and nausea Amylin Agonism Reduces appetite, food intake, glucagon production, and gastric emptying Increases energy expenditure Reduces bone resorption and increases bone production PYY Agonism Reduces appetite, food intake, and gastric emptying Increases energy expenditure and nausea The Cost Challenge for Payers The cost of GLP-1s continues to be a significant concern for payers between skyrocketing costs and utilization over the past several years